Immunovant Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $109.4M
Liabilities Breakdown FY2020
Total Liabilities: $15.3M
Asset Breakdown
Total Assets: $109.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $100.6M | 91.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $65.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.8M | 8.0% |
Liabilities Breakdown
Total Liabilities: $15.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 7.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $14.1M | 92.2% |